Enthusiasm for personalized medicine is premature, prominent public health scholars argue

The increasing national focus on personalized or ‘precision’ medicine is misguided, distracting from broader investments to reduce health inequities and address the social factors that affect population health, two leading public health scholars argue. While investments in precision medicine may ultimately ‘open new vistas of science,’ enthusiasm about the promise of this research is premature, they say.